We have developed a novel approach using an allogeneic plasmacytoid dendritic cell (PDC) line as an antigen-presentation platform showing great potency to prime and expand viral or tumor-specific CD8+ T cells in vitro and in vivo in a humanized mouse model [55–65]. The gene discussed is CD8A; the disease is neoplasm.